A 3-year-old boy from rural Maharashtra presents with a 2-day history of fever, irritability, and neck stiffness. On examination, he is febrile (39.2°C), has a positive Kernig sign, and appears acutely ill. CSF analysis shows: WBC 180/μL (90% neutrophils), protein 120 mg/dL, glucose 25 mg/dL (serum glucose 90 mg/dL), and Gram stain reveals pleomorphic gram-negative coccobacilli. Blood and CSF cultures are pending. What is the most appropriate empirical antibiotic regimen for this child?

Explanation

## Clinical Diagnosis **Key Point:** The CSF profile (low glucose, elevated protein, neutrophilic pleocytosis) combined with Gram stain showing pleomorphic gram-negative coccobacilli is pathognomonic for *Haemophilus influenzae* meningitis. ## Empirical Therapy Rationale **High-Yield:** In children with bacterial meningitis, empirical therapy MUST cover *H. influenzae* (type b), *Streptococcus pneumoniae*, and *Neisseria meningitidis* until culture identifies the organism. **Clinical Pearl:** Third-generation cephalosporins (ceftriaxone, cefotaxime) achieve excellent CSF penetration and are the backbone of meningitis therapy. However, vancomycin MUST be added empirically in children because: - Emerging penicillin-resistant *S. pneumoniae* strains may not be reliably killed by cephalosporins alone - Vancomycin achieves adequate CSF levels when meninges are inflamed - This combination covers all three major pathogens **Mnemonic: CAV** — **C**ephalosporin (3rd gen) + **A**minoglycoside (optional in some guidelines) + **V**ancomycin ### Why This Regimen Works | Antibiotic | Target Organism | CSF Penetration | Rationale | |---|---|---|---| | Ceftriaxone | *H. influenzae*, *N. meningitidis*, *S. pneumoniae* (susceptible) | Excellent (20–30% of serum) | First-line for meningitis; bactericidal | | Vancomycin | *S. pneumoniae* (resistant strains) | Adequate when inflamed meninges | Covers penicillin-resistant strains | **Dosing in meningitis:** - Ceftriaxone: 80 mg/kg/day (max 4 g/day) divided 6-hourly - Vancomycin: 15 mg/kg/dose 6-hourly (target trough 15–20 μg/mL) [cite:Harrison 21e Ch 139]